Timothy Li is a consultant, accountant, and finance manager with an MBA from USC and over 15 years of corporate finance experience. Timothy has helped provide CEOs and CFOs with deep-dive ...
The phrase “passive income” may have different meanings to different people, so let’s define how I am using it in this article before highlighting a trio of stocks that can provide it.
While facing 2028 patent cliffs, Bristol-Myers Squibb and Merck maintain top-tier dividend yields. Recent market volatility has created an attractive entry point for both stocks heading into 2025.